Payment overview · 2025
General Payments
$53.17
2 reported records · 2 companies
Healthcare provider profile · identity verified
Stacey E Bishop Yeatman, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · HIGHLAND HEIGHTS, KY · NPI 1770520975
Verified facts
What the public records show
CMS Open Payments records show Stacey E Bishop Yeatman, M.D. received $53.17 in general payments during 2025 across 2 reported records.
Alkermes, Inc. accounted for 58.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $31.29 | 58.9% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $21.88 | 41.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $53.17 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VIVITROL Normalized: vivitrol |
Drug | Alkermes, Inc. | $31.29 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $21.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 440 | 128 |
| Levothyroxine Sodium | Levothyroxine Sodium | 364 | 92 |
| Lisinopril | Lisinopril | 301 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 294 | 84 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 213 | 63 |
| Omeprazole | Omeprazole | 207 | 61 |
| Gabapentin | Gabapentin | 205 | 42 |
| Metoprolol Succinate | Metoprolol Succinate | 156 | 46 |
| Alendronate Sodium | Alendronate Sodium | 154 | 39 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 140 | 35 |
| Metformin Hcl | Metformin Hcl | 140 | 37 |
| Alprazolam | Alprazolam | 136 | 19 |
| Losartan Potassium | Losartan Potassium | 133 | 39 |
| Simvastatin | Simvastatin | 131 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 126 | 37 |
| Sertraline Hcl | Sertraline Hcl | 112 | 33 |
| Lorazepam | Lorazepam | 104 | 25 |
| Furosemide | Furosemide | 103 | 35 |
| Allopurinol | Allopurinol | 95 | 22 |
| Meloxicam | Meloxicam | 93 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 91 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 89 | 30 |
| Trazodone Hcl | Trazodone Hcl | 84 | 28 |
| Eliquis | Apixaban | 83 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 21 |
| Tramadol Hcl | Tramadol Hcl | 83 | 21 |
| Potassium Chloride | Potassium Chloride | 80 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 76 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 71 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 70 | 26 |
| Glipizide | Glipizide | 70 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 70 | 19 |
| Metformin Hcl Er | Metformin Hcl | 62 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 60 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 59 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 57 | 18 |
| Synthroid | Levothyroxine Sodium | 51 | 18 |
| Carvedilol | Carvedilol | 50 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 49 | 14 |
| Clonazepam | Clonazepam | 47 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | 13 |
| Buspirone Hcl | Buspirone Hcl | 43 | 13 |
| Glimepiride | Glimepiride | 43 | suppressed |
| Spironolactone | Spironolactone | 43 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 41 | 14 |
| Cephalexin | Cephalexin | 39 | 28 |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 38 | 12 |
| Prednisone | Prednisone | 38 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 37 | 11 |
| Finasteride | Finasteride | 37 | suppressed |
| Ozempic | Semaglutide | 37 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | suppressed |
| Diazepam | Diazepam | 34 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 32 | 12 |
| Atenolol | Atenolol | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Myrbetriq | Mirabegron | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Temazepam | Temazepam | 26 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Ezetimibe | Ezetimibe | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 17 |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Eszopiclone | Eszopiclone | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Azithromycin | Azithromycin | 19 | 19 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 15 |
| Klor-Con M20 | Potassium Chloride | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 14 |
| Estradiol | Estradiol | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Ranolazine Er | Ranolazine | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 15 | suppressed |
| Famotidine | Famotidine | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Jardiance | Empagliflozin | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Digoxin | Digoxin | 11 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $53.17 · 2 records | Alkermes, Inc. | Dexcom G6 Transmitter, VIVITROL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error